LOS ANGELES, July 1, 2014 /PRNewswire/ -- Medbox, Inc.
(OTCQB: MDBX) (www.medbox.com), a leading dispensary
infrastructure/licensing specialist, patented technology provider,
and partner to the cannabis industry, today announced that the
company's Form 10 filing has been deemed effective by the
Securities and Exchange Commission, with no outstanding comments
left to address.
Dr. Bruce Bedrick, CEO of Medbox,
commented, "This step is another milestone for our Company as we
continue to build market leadership in the cannabis industry.
We believe that compliance and transparency are important for our
industry to thrive, and for Medbox to grow as a public
company."
About Medbox, Inc.
Medbox (http://www.medbox.com) is the leading dispensary
infrastructure and licensing specialist, patented technology
provider, and partner to the cannabis industry. Headquartered in
Los Angeles, CA, Medbox, through
its wholly owned subsidiary, Medicine Dispensing Systems, offers
its patented systems, software and consulting services to
pharmacies, alternative medicine dispensaries and local governments
in the U.S. In addition, through its wholly owned subsidiary,
Vaporfection International, Inc. (www.vaporfection.com), the
company offers an industry award winning medical vaporizer product.
Medbox, through its newly established subsidiaries, is in
development of the following ancillary services tailored to the
alternative medicine industry: merchant services and armored
transport for cash deposits, cannabidiol research and development,
real estate acquisitions and subsequent lease programs to
alternative medicine dispensaries, and alternative medicine
dispensary management services.
Forward-Looking Statements
Statements in this press release constitute forward-looking
statements within the meaning of federal securities laws. Such
statements are based on our current beliefs and expectations and
are inherently subject to significant business, economic and
competitive uncertainties and contingencies, many of which are
beyond our control. In addition, such forward-looking statements
are subject to assumptions with respect to future business
strategies and decisions that are subject to change. Potential
risks and uncertainties include, but are not limited to, technical
advances in the industry as well as political and economic
conditions present within the industry. We do not undertake any
obligation to update any forward-looking statement to reflect
events or developments after a forward-looking statement was
made.
Contact Information
Investor Relations:
Stephen Hart
Hayden IR
+1- 917-658-7878
hart@haydenir.com
Medbox:
For more information on Medbox, please call (800) 762-1452.
SOURCE Medbox, Inc.